Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:39 PM
Ignite Modification Date:
2025-12-26 @ 2:39 PM
NCT ID:
NCT01608906
Eligibility Criteria:
Inclusion Criteria:
* A signed informed consent;
* Age between 18 and 80 years
* The patient is admitted to the surgical intensive care unit at the University of Colorado Hospital
Exclusion Criteria:
* Predicated SICU stay less than 5 days;
* Pregnancy;
* Breast feeding;
* Initial platelet count \< 30,000;
* Currently eligible for treatment of thromboembolism;
* Prior organ transplant;
* Cardiopulmonary bypass within previous 30 days;
* Advanced directive precluding participation;
* Already receiving pharmacologic agent for DVT prophylaxis;
* Prior diagnosis of heparin-induced thrombocytopenia;
* Heparin allergy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01608906
Study Brief:
Protocol Section:
NCT01608906